Endometriosis is a chronic inflammatory condition that can cause painful periods, pelvic pain, and bowel or bladder symptoms
Any new or worsening symptoms while on therapy, including severe abdominal pain, persistent nausea or vomiting, or signs of gallbladder disease, require prompt medical evaluation
Clinic Implementation Guidelines - Confirm all consents are signed before treatment.- Educate the patient on proper application and expected results.- Store GHK-Cu formulations per compounding pharmacy recommendations.- Schedule follow-up to assess efficacy and tolerance
Current FDA-Approved GLP-1s for Weight Loss Wegovy uses semaglutide at 2.4 mg weekly and achieved sustained mean weight loss of about 15 percent at two years in STEP5, with most adverse events being GI and mild to moderate
"If we treat addiction and compulsion and anhedonia, we cannot be ignoring a class of drugs that really directly acts in the reinforcement system," he said